- RIUMA Principal
- Listar por autor
Listar por autor "Marchal, Juan Antonio"
Mostrando ítems 1-3 de 3
-
Anti-CD44-Conjugated Olive Oil Liquid Nanocapsules for Targeting Pancreatic Cancer Stem Cells
Navarro-Marchal, Saúl; Griñan-Lisan, Carmen; Entrena, José Manuel; Ruiz-Alcalá, Gloria; Tristán-Manzano, María; Martín, Francisco; Pérez-Victoria, Ignacio; Peula-García, José Manuel; Marchal, Juan Antonio[et al.] (ACS Publications, 2021-03)The latest trends in cancer research and nanomedicine focus on using nanocarriers to target cancer stem cells (CSCs). Specifically, lipid liquid nanocapsules are usually developed as nanocarriers for lipophilic drug delivery. ... -
Effect of the protein corona formation on antibody functionalized liquid lipid nanocarriers
Navarro-Marchal, Saúl; Martín Contreras, Marina; Castro-Santiago, David; del Castillo-Santaella, Teresa; Graván, Pablo; Jódar-Reyes, Ana Belén; Marchal, Juan Antonio; Peula-García, José Manuel[et al.] (MDPI, 2023-11)The main aim of this study is to report basic knowledge on how a protein corona (PC) could affect or modify the way in which multifunctionalized nanoparticles interact with cells. With this purpose, we have firstly optimized ... -
Smart drug-delivery systems for cancer nanotherapy
Sánchez-Moreno, Paola; Ortega-Vinuesa, Juan Luis; Peula-García, José Manuel; Marchal, Juan Antonio; Boulaiz, Houria (Bentham Science, 2018-02)Despite all the advances achieved in the field of tumor-biology research, in most cases conventional therapies including chemotherapy are still the leading choices. The main disadvantage of these treatments, in addition ...